Direct-acting antiviral therapy and diverse viral infections require comprehensive epidemiological and diagnostic strategy review
Review Outlines Treatment and Prevention for Various Viral Infections
This systematic review covers the molecular biology, epidemiology, and treatment strategies for various viral infections including Hepatitis…
A comprehensive review outlines the biological traits, diagnosis methods, and treatment strategies for several common viral infections inclu…
LLM-derived embeddings outperform tabular models for end-of-therapy outcome prediction in tuberculosis patients
New Data Models Improve Prediction of Tuberculosis Treatment Success
This analysis of Phase 3 clinical trial data involving 2,918 participants evaluated time-resolved prediction models for tuberculosis outcome…
Advanced data models may help doctors better predict if tuberculosis patients will successfully complete treatment or face a relapse.
Good antiretroviral therapy adherence is associated with a 6.30 odds ratio for viral load suppression
Better adherence to HIV treatment links to lower viral loads
This meta-analysis of 39 studies in Ethiopia evaluates the relationship between antiretroviral therapy adherence and viral load suppression …
Staying consistent with daily HIV medication is strongly linked to lower viral loads, helping people living with HIV manage their health mor…
Ervebo and Zabdeno/Mvabea vaccines show significant differences in antibody cross-reactivity to Bundibugyo virus
Ebola vaccines show limited protection against Bundibugyo virus disease
This meta-analysis evaluates antibody cross-reactivity and protection against Bundibugyo virus (BDBV) following Ervebo or Zabdeno/Mvabea vac…
New data shows that while some Ebola vaccines provide some protection against Bundibugyo virus, the level of cross-protection is quite limit…
Impact of Intrawound Vancomycin on Surgical Site Infection and Outcomes in Spinal Fusion
Vancomycin use in spinal surgery does not lower infection rates
A retrospective analysis of 3,311 patients reveals that intrawound vancomycin does not reduce surgical site infection rates in posterior spi…
A large study of spinal surgery patients found that using vancomycin directly in the wound did not reduce the risk of surgical site infectio…
Antigen delivery and immune programming are the primary hurdles for H. pylori vaccine development
Vaccine Development Faces Challenges for H. pylori Infections
This narrative review examines the current landscape of H. pylori vaccine development for conditions like gastritis and gastric cancer. The …
New research identifies why H. pylori vaccines have struggled to move from laboratory success to clinical protection for patients with stoma…
Capmatinib identified as a promising candidate for repurposing against Mpox via in silico screening
Computer models identify potential new drugs to fight Mpox
This guideline provides an in silico study identifying capmatinib, nebivolol, and tucatinib as potential candidates for targeting MPXV thymi…
Researchers used computer simulations to identify three existing drugs that might be repurposed to treat Mpox infections.
Ceftolozane-tazobactam associated with higher clinical cure rates in multidrug-resistant Pseudomonas aeruginosa infections
Comparing Two Different Antibiotics for Treating Tough Pseudomonas Aeruginosa Infections
Researchers compared ceftolozane-tazobactam and ceftazidime-avibactam for treating multidrug-resistant and difficult-to-treat Pseudomonas ae…
Doctors are comparing two powerful antibiotics to see which one works best against hard-to-treat bacterial infections.
Peg-interferon add-on to nucleoside analogues achieves HBsAg loss in 8.6% of patients
Adding peg-interferon to standard treatment helps some hepatitis B patients
This meta-analysis of 581 patients with chronic hepatitis B evaluates peg-interferon add-on to nucleoside analogue therapy. The analysis fou…
Adding peg-interferon to standard nucleoside therapy can help some patients with chronic hepatitis B achieve a key milestone in their treatm…
Islatravir 60 mg oral qm showed 64.3% adverse event rate compared to 77.1% in comparator
Trial Shows Islatravir Shows Tolerable Safety Profile for HIV Prevention
This Phase 3 randomized trial evaluated islatravir 60 mg oral qm in 494 cisgender men and transgender women at increased risk of HIV-1 expos…
A Phase 3 trial of islatravir for HIV prevention showed the medication was generally well tolerated with fewer reported side effects than th…
Monoclonal antibodies and various vaccine platforms show potential for human metapneumovirus prevention in children
New research explores ways to protect children from metapneumovirus
This narrative review examines the development of monoclonal antibodies and vaccines for human metapneumovirus (hMPV) in pediatric populatio…
Scientists are looking at new ways to protect children from metapneumovirus using both vaccines and monoclonal antibodies.
No Reproducible Microbial Signature Found in Medication-Related Osteonecrosis of the Jaw
Microbial Signatures Linked to Medication Related Jaw Bone Damage
This systematic review and evidence map examined microbiological findings across 67 independent studies (51 MRONJ studies, 16 contextual stu…
New research looks at the types of bacteria and fungi found in jawbone tissue following certain medications to identify specific microbial p…